WuXi Biologics (Cayman) Inc. Sustainability Reports
A global contract research, development, and manufacturing organization (CRDMO) providing end-to-end solutions for biologics discovery, development, and manufacturing.
Sector: Professional & technical services
Country: China
Exchange: Hong Kong Stock Exchange
ISIN: KYG970081173
16 reports from 2017 to 2025